Home / Stocks / NBY

NBY insider trading

NovaBay Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$314k
Buys · last 90 days
0 · $0
Most recent buy
2025-04-15

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-04-15FAKHRY JAD
10% owner
Bought102,388$0.66$68k
2025-04-15FAKHRY JAD
10% owner
Bought84,487$0.66$56k
2025-04-15FAKHRY JAD
10% owner
Bought48,930$0.61$30k
2025-04-15FAKHRY JAD
10% owner
Bought64,175$0.62$39k
2025-04-15FAKHRY JAD
10% owner
Bought49,927$0.62$31k
2025-04-15FAKHRY JAD
10% owner
Bought123,365$0.60$75k
2025-04-15FAKHRY JAD
10% owner
Bought28,731$0.55$16k

Most active insider buyers

InsiderRoleBuysTotal bought
FAKHRY JAD10% owner7$314k

See NBY on the chart

Every insider buy and sell for NBY plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.